---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-058429"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2026-05-18T20:05:41+00:00"
generated_at: "2026-05-18T20:13:20.241504+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve 6M extra shares for equity plan and 1.2M for ESPP

## Summary
- 6,000,000 additional shares authorized under Amended and Restated 2023 Equity Incentive Plan (effective May 12, 2026).
- 1,200,000 additional shares authorized under 2023 Employee Stock Purchase Plan.
- Stockholders re-elected directors Brent T. Lucas and Susan J. Kantor to Class III terms until 2029.
- Ratified EisnerAmper LLP as independent auditor for fiscal year ending December 31, 2026.
- Approved advisory executive compensation and issuance of warrants per Nasdaq Rule 5635(d).

## SEC filing metadata
- accession: 0001213900-26-058429
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2026-05-18T20:05:41+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/0001213900-26-058429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/ea0291354-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-058429
- JSON: https://secwatch.observer/filing/0001213900-26-058429.json
- Plain text: https://secwatch.observer/filing/0001213900-26-058429.txt

## Key facts
- Shareholder Votes
  Envoy Medical, Inc. shareholders approved Election of two Class III director nominees, Brent T. Lucas and Susan J. Kantor at the 2026-05-18 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-18
  source text: 1. The Company’s stockholders elected two Class III director nominees, Brent T. Lucas and Susan J. Kantor, to the Company’s Board of Directors to hold office until the earlier of the 2029 annual meeting of stockholders, the election of such director’s successor, or such director’s death, resignation or removal;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/0001213900-26-058429-index.htm
- Shareholder Votes
  Envoy Medical, Inc. shareholders approved Amendment to the Employee Stock Purchase Plan to authorize an additional 1,200,000 shares of Common Stock for issuance under such plan at the 2026-05-18 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-05-18
  source text: 5. Stockholders approved an amendment to the Employee Stock Purchase Plan to authorize an additional 1,200,000 shares of Common Stock for issuance under such plan;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/0001213900-26-058429-index.htm
- Shareholder Votes
  Envoy Medical, Inc. shareholders approved Amendment to the Equity Incentive Plan to authorize an additional 6,000,000 shares of Common Stock for issuance under such plan at the 2026-05-18 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-05-18
  source text: 4. Stockholders approved an amendment to the Equity Incentive Plan to authorize an additional 6,000,000 shares of Common Stock for issuance under such plan;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/0001213900-26-058429-index.htm
- Shareholder Votes
  Envoy Medical, Inc. shareholders approved Approval, on a non-binding and advisory basis, of the compensation of the Company's named executive officers at the 2026-05-18 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-05-18
  source text: 3. Stockholders approved, on a non-binding and advisory basis, the compensation of the Company’s named executive officers;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/0001213900-26-058429-index.htm
- Shareholder Votes
  Envoy Medical, Inc. shareholders approved Approval for the purposes of complying with Nasdaq Listing Rule 5635(d) of the issuance of warrants to purchase shares of Common Stock and the issuance of Class A Common Stock underlying such warrants issued in a transaction completed on February 12, 2026 at the 2026-05-18 meeting.
  - Outcome: passed
  - Meeting: 2026-05-18
  source text: 6. Stockholders approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of warrants to purchase shares of the Common Stock, and the issuance of Class A Common Stock underlying such warrants, that were issued in a transaction that was completed on February 12, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/0001213900-26-058429-index.htm
- Shareholder Votes
  Envoy Medical, Inc. shareholders approved Ratification of the appointment of EisnerAmper, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-18 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-18
  source text: 2. Stockholders ratified the appointment of EisnerAmper, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/0001213900-26-058429-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.